Tscan Therapeutics, Inc.(TCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TCRX Tscan Therapeutics, Inc.

已收盘 07-16 16:00:00 EDT

1.81

+0.04

+2.26%

盘后1.84

+0.03+1.66%

19:52 EDT

最高1.86	最低1.76	成交量30.46万
今开1.79	昨收1.77	日振幅5.33%
总市值1.02亿	流通市值7,369万	总股本5,659万
成交额54.87万	换手率0.75%	流通股本4,071万
市净率0.49	ROE-78.93%	每股收益-2.32
52周最高7.89	52周最低1.02	市盈率-0.78
股息0.00	股息收益率0.00	ROA-30.45%

北京优虎网络科技有限公司

{"stockData":{"symbol":"TCRX","market":"US","secType":"STK","nameCN":"Tscan Therapeutics, Inc.","latestPrice":1.81,"timestamp":1752696000000,"preClose":1.77,"halted":0,"volume":304579,"hourTrading":{"tag":"盘后","latestPrice":1.84,"preClose":1.81,"latestTime":"19:52 EDT","volume":6113,"amount":11315.385,"timestamp":1752709972984},"delay":0,"floatShares":40710550,"shares":56590627,"eps":-2.323423,"marketStatus":"已收盘","change":0.04,"latestTime":"07-16 16:00:00 EDT","open":1.79,"high":1.8561,"low":1.7618,"amount":548707.6576278,"amplitude":0.053277,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.323423,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752739200000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1626408000000,"exchange":"NASDAQ","adjPreClose":1.77,"dividendRate":0.000552,"preHourTrading":{"tag":"盘前","latestPrice":1.84,"preClose":1.77,"latestTime":"08:56 EDT","volume":5661,"amount":10416.9402657,"timestamp":1752670585530},"postHourTrading":{"tag":"盘后","latestPrice":1.84,"preClose":1.81,"latestTime":"19:52 EDT","volume":6113,"amount":11315.385,"timestamp":1752709972984},"volumeRatio":0.984153},"requestUrl":"/m/hq/s/TCRX","defaultTab":"news","newsList":[{"id":"2537880944","title":"Tscan Therapeutics, Inc.盘中异动 大幅拉升8.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537880944","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537880944?lang=zh_cn&edition=full","pubTime":"2025-05-22 21:31","pubTimestamp":1747920669,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日21时31分，Tscan Therapeutics, Inc.股票出现异动，股价急速拉升8.71%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。其相关个股中，Vigil Neuroscience, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Biodexa Pharmaceuticals Plc涨幅较大，Biodexa Pharmaceuticals Plc、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为1225.87%、818.94%、334.09%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Aura Biosciences, Inc.、Instil Bio, Inc.，振幅分别为24.71%、8.99%、8.20%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522213109a6e8f131&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522213109a6e8f131&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","BK4539","TCRX","LENZ"],"gpt_icon":0},{"id":"2537930296","title":"Tscan Therapeutics, Inc.盘中异动 股价大涨5.79%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537930296","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537930296?lang=zh_cn&edition=full","pubTime":"2025-05-22 00:27","pubTimestamp":1747844872,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日00时27分，Tscan Therapeutics, Inc.股票出现异动，股价急速拉升5.79%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052200275294fe260a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052200275294fe260a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","BK4539","TCRX"],"gpt_icon":0},{"id":"2535078054","title":"Tscan Therapeutics, Inc.盘中异动 大幅拉升9.86%报1.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535078054","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535078054?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:38","pubTimestamp":1747229883,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时38分，Tscan Therapeutics, Inc.股票出现异动，股价快速拉升9.86%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Septerna, Inc.、蓝鸟生物、Quoin Pharmaceuticals Ltd涨幅较大，Nucana Plc、Polyrizon Ltd.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为2201.18%、1448.03%、1251.93%，振幅较大的相关个股有Humacyte Inc C/Wts 27/08/2026 、Nucana Plc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为46.33%、23.40%、20.77%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213803aa2c8e52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213803aa2c8e52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TCRX","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2534271955","title":"Tscan Therapeutics, Inc.盘中异动 股价大涨6.69%报1.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534271955","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534271955?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:37","pubTimestamp":1747057077,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时37分，Tscan Therapeutics, Inc.股票出现异动，股价快速上涨6.69%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.59%。其相关个股中，Cytomx Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、艾吉纳斯涨幅较大，Nucana Plc、Cytomx Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为350.41%、72.79%、59.49%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、艾吉纳斯、Engene Holdings Inc.，振幅分别为49.55%、29.55%、21.28%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213808a47b7997&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213808a47b7997&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LENZ","BK4007","TCRX"],"gpt_icon":0},{"id":"2534823806","title":"Tscan Therapeutics, Inc.2025财年第一财季实现净利润-34.13百万美元，同比减少13.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534823806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534823806?lang=zh_cn&edition=full","pubTime":"2025-05-12 00:00","pubTimestamp":1746979249,"startTime":"0","endTime":"0","summary":"5月12日，Tscan Therapeutics, Inc.公布财报，公告显示公司2025财年第一财季净利润为-34.13百万美元，同比减少13.24%；其中营业收入为2.17百万美元，同比增加283.39%，每股基本收益为-0.26美元。从资产负债表来看，Tscan Therapeutics, Inc.总负债1.23亿美元，其中短期债务4.97百万美元，资产负债比为2.71，流动比率为0.09。机构评级：截至2025年5月12日，当前有7家机构对Tscan Therapeutics, Inc.目标价做出预测，其中目标均价为9.00美元，其中最低目标价为3.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512000213a47a4937&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512000213a47a4937&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TCRX"],"gpt_icon":0},{"id":"2534492454","title":"Tscan Therapeutics, Inc.盘中异动 大幅跳水5.80%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534492454","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534492454?lang=zh_cn&edition=full","pubTime":"2025-05-10 02:16","pubTimestamp":1746814577,"startTime":"0","endTime":"0","summary":"北京时间2025年05月10日02时16分，Tscan Therapeutics, Inc.股票出现波动，股价快速跳水5.80%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.68%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。消息层面，截至02时16分，《HC Wainwright & Co.：维持TScan Therapeutics评级，由买入调整至买入评级, 目标价由15.00美元调整至10.00美元。》资讯为影响Tscan Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505100216179754c40f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505100216179754c40f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCRX","BK4539","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2533153975","title":"Tscan Therapeutics, Inc.盘中异动 大幅上涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533153975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533153975?lang=zh_cn&edition=full","pubTime":"2025-05-08 23:48","pubTimestamp":1746719298,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日23时48分，Tscan Therapeutics, Inc.股票出现异动，股价快速拉升5.15%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.39%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。消息层面，截至23时48分，《HC Wainwright & Co.：维持TScan Therapeutics评级，由买入调整至买入评级, 目标价由15.00美元调整至10.00美元。》资讯为影响Tscan Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508234818aa2c87db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508234818aa2c87db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCRX","BK4539","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2533971936","title":"Tscan Therapeutics, Inc.盘中异动 早盘急速拉升5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533971936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533971936?lang=zh_cn&edition=full","pubTime":"2025-05-07 21:37","pubTimestamp":1746625060,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日21时37分，Tscan Therapeutics, Inc.股票出现波动，股价大幅上涨5.48%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。消息层面，截至21时37分，《HC Wainwright & Co.：维持TScan Therapeutics评级，由买入调整至买入评级, 目标价由15.00美元调整至10.00美元。》资讯为影响Tscan Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050721374094ef52aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050721374094ef52aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","LENZ","BK4139","TCRX"],"gpt_icon":0},{"id":"2533630059","title":"Tscan Therapeutics, Inc.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533630059","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533630059?lang=zh_cn&edition=full","pubTime":"2025-05-06 21:44","pubTimestamp":1746539062,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日21时44分，Tscan Therapeutics, Inc.股票出现波动，股价快速下跌5.00%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.29%。其相关个股中，Pasithea Therapeutics Corp.、Liminatus Pharma Inc C/Wts 30/04/2030 、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Pasithea Therapeutics Corp.、Galmed Pharmaceuticals Ltd.、Nucana Plc较为活跃，换手率分别为2190.96%、894.77%、235.94%，振幅较大的相关个股有Pasithea Therapeutics Corp.、Liminatus Pharma Inc C/Wts 30/04/2030 、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为53.52%、38.46%、22.46%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505062144239750c28a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505062144239750c28a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LENZ","BK4007","TCRX"],"gpt_icon":0},{"id":"2532782159","title":"Tscan Therapeutics, Inc.盘中异动 临近午盘大幅拉升5.16%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532782159","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532782159?lang=zh_cn&edition=full","pubTime":"2025-05-02 23:54","pubTimestamp":1746201273,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日23时54分，Tscan Therapeutics, Inc.股票出现波动，股价快速上涨5.16%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.08%。其相关个股中，Polyrizon Ltd.、Impact Biomedical, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Impact Biomedical, Inc.、Pmgc Holdings Inc.、Polyrizon Ltd.较为活跃，换手率分别为1139.74%、745.85%、595.64%，振幅较大的相关个股有Polyrizon Ltd.、Impact Biomedical, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为267.88%、119.72%、71.36%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050223543394ead4fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050223543394ead4fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","BK4539","TCRX","LENZ"],"gpt_icon":0},{"id":"2531305639","title":"Tscan Therapeutics, Inc.盘中异动 早盘大幅下跌5.03%报1.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531305639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531305639?lang=zh_cn&edition=full","pubTime":"2025-04-30 21:49","pubTimestamp":1746020955,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日21时49分，Tscan Therapeutics, Inc.股票出现异动，股价快速跳水5.03%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Regulus Therapeutics Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Purple Biotech Ltd、Regulus Therapeutics Inc.、Silo Pharma, Inc.较为活跃，换手率分别为132.96%、22.32%、11.74%，振幅较大的相关个股有Nutriband Inc.、Regulus Therapeutics Inc.、Polypid Ltd.，振幅分别为29.23%、14.54%、14.43%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043021491594e90a8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043021491594e90a8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","BK4539","TCRX","LENZ"],"gpt_icon":0},{"id":"2530131492","title":"Tscan Therapeutics, Inc.盘中异动 早盘股价大跌7.56%报1.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530131492","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530131492?lang=zh_cn&edition=full","pubTime":"2025-04-25 21:31","pubTimestamp":1745587876,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日21时31分，Tscan Therapeutics, Inc.股票出现异动，股价大幅跳水7.56%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Azitra Inc、Geovax Labs, Inc.、Lixte Biotechnology Holdings, Inc.涨幅较大，Azitra Inc、Briacell Therapeutics Corp.、Acrivon Therapeutics, Inc.较为活跃，换手率分别为183.00%、40.61%、40.17%，振幅较大的相关个股有Acrivon Therapeutics, Inc.、Polyrizon Ltd.、X4制药，振幅分别为8.22%、7.22%、7.00%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213116a6c81cd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213116a6c81cd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCRX","LENZ","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2529584692","title":"Tscan Therapeutics, Inc.盘中异动 股价大跌5.23%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529584692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529584692?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:55","pubTimestamp":1745330135,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时55分，Tscan Therapeutics, Inc.股票出现异动，股价急速下挫5.23%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.07%。其相关个股中，60 Degrees Pharmaceuticals, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、阿诺医药涨幅较大，Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为182.49%、95.92%、64.75%，振幅较大的相关个股有Scorpius Holdings, Inc.、Vincerx Pharma, Inc.、60 Degrees Pharmaceuticals, Inc.，振幅分别为102.79%、33.76%、30.03%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504222155359740c044&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504222155359740c044&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","BK4139","LENZ","TCRX"],"gpt_icon":0},{"id":"2529385538","title":"Tscan Therapeutics, Inc.盘中异动 早盘股价大涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529385538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529385538?lang=zh_cn&edition=full","pubTime":"2025-04-21 22:14","pubTimestamp":1745244891,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时14分，Tscan Therapeutics, Inc.股票出现异动，股价快速上涨5.56%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Dogwood Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大，Aptevo Therapeutics Inc.、Dogwood Therapeutics, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为997.90%、659.36%、267.07%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Traws Pharma, Inc.，振幅分别为58.81%、43.24%、32.32%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421221451973f7c42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421221451973f7c42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","LENZ","BK4139","TCRX"],"gpt_icon":0},{"id":"2528743734","title":"Tscan Therapeutics, Inc.盘中异动 股价大涨5.38%报1.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528743734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528743734?lang=zh_cn&edition=full","pubTime":"2025-04-17 21:47","pubTimestamp":1744897675,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日21时47分，Tscan Therapeutics, Inc.股票出现波动，股价快速拉升5.38%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Channel Therapeutics Corporation、Uniqure N.V.、硕迪生物涨幅较大，Channel Therapeutics Corporation、Clearmind Medicine Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为431.79%、150.99%、81.19%，振幅较大的相关个股有Processa Pharmaceuticals, Inc.、Channel Therapeutics Corporation、Uniqure N.V.，振幅分别为43.27%、36.65%、17.25%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417214756973b5611&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417214756973b5611&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","TCRX","BK4539","BK4139"],"gpt_icon":0},{"id":"2527432734","title":"Tscan Therapeutics, Inc.盘中异动 早盘股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527432734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527432734?lang=zh_cn&edition=full","pubTime":"2025-04-15 22:17","pubTimestamp":1744726628,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日22时17分，Tscan Therapeutics, Inc.股票出现异动，股价快速拉升5.24%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。其相关个股中，Mural Oncology Plc、Skye Bioscience, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Mural Oncology Plc、Metavia Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为772.30%、227.28%、89.75%，振幅较大的相关个股有Skye Bioscience, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Mural Oncology Plc，振幅分别为171.53%、80.08%、66.02%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415221708a459d21a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415221708a459d21a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4139","BK4007","TCRX"],"gpt_icon":0},{"id":"2518220126","title":"Tscan Therapeutics, Inc.盘中异动 股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220126","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518220126?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:49","pubTimestamp":1741628968,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时49分，Tscan Therapeutics, Inc.股票出现波动，股价急速下跌5.30%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。其相关个股中，Aeon Biopharma, Inc.、Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为5466.60%、3825.64%、991.14%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、58.34%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311014928abf35ac8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311014928abf35ac8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCRX","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2518748289","title":"Tscan Therapeutics, Inc.2024财年实现净利润-1.27亿美元，同比减少42.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518748289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518748289?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:00","pubTimestamp":1741536046,"startTime":"0","endTime":"0","summary":"3月10日，Tscan Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-1.27亿美元，同比减少42.34%；其中营业收入为2.82百万美元，同比减少86.60%，每股基本收益为-1.14美元。从资产负债表来看，Tscan Therapeutics, Inc.总负债1.30亿美元，其中短期债务4.57百万美元，资产负债比为2.86，流动比率为0.09。机构评级：截至2025年3月10日，当前有7家机构对Tscan Therapeutics, Inc.目标价做出预测，其中目标均价为10.29美元，其中最低目标价为3.00美元，最高目标价为15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000113a268980a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000113a268980a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TCRX"],"gpt_icon":0},{"id":"2517443609","title":"Tscan Therapeutics, Inc.盘中异动 股价大跌5.45%报1.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517443609","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517443609?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:43","pubTimestamp":1741193030,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时43分，Tscan Therapeutics, Inc.股票出现异动，股价快速下挫5.45%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.04%。其相关个股中，Chimerix, Inc.、Nutriband Inc C/Wts 、Celularity Inc.涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为912.60%、299.54%、282.78%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为82.59%、54.27%、41.26%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306004351abe9d8d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306004351abe9d8d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","TCRX","LENZ","BK4139"],"gpt_icon":0},{"id":"2517310944","title":"Needham：维持TScan Therapeutics(TCRX.US)评级，由买入调整至买入评级, 目标价由11.00美元调整至9.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517310944","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517310944?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:41","pubTimestamp":1741192881,"startTime":"0","endTime":"0","summary":"Needham：维持TScan Therapeutics(TCRX.US)评级，由买入调整至买入评级, 目标价由11.00美元调整至9.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06004148550592.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["TCRX","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tscan.com","stockEarnings":[{"period":"1week","weight":0.0412},{"period":"1month","weight":0.1419},{"period":"3month","weight":0.3615},{"period":"6month","weight":-0.2805},{"period":"1year","weight":-0.7507},{"period":"ytd","weight":-0.4178}],"compareEarnings":[{"period":"1week","weight":0.0029},{"period":"1month","weight":0.0421},{"period":"3month","weight":0.1835},{"period":"6month","weight":0.0516},{"period":"1year","weight":0.1079},{"period":"ytd","weight":0.0615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"TScan Therapeutics, Inc.于2018年4月17日在特拉华州注册成立。该公司是一家临床前阶段的生物制药公司，专注于开发强大的T细胞受体工程T细胞或TCR-T疗法，用于治疗癌症患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.007644},{"month":2,"riseRate":0.5,"avgChangeRate":0.157126},{"month":3,"riseRate":0.25,"avgChangeRate":-0.197008},{"month":4,"riseRate":0.5,"avgChangeRate":-0.003964},{"month":5,"riseRate":0.75,"avgChangeRate":0.125017},{"month":6,"riseRate":0.5,"avgChangeRate":-0.058009},{"month":7,"riseRate":0.75,"avgChangeRate":0.183267},{"month":8,"riseRate":0.25,"avgChangeRate":-0.151516},{"month":9,"riseRate":0.5,"avgChangeRate":0.00185},{"month":10,"riseRate":0.5,"avgChangeRate":0.08779},{"month":11,"riseRate":0.5,"avgChangeRate":0.105298},{"month":12,"riseRate":0,"avgChangeRate":-0.291205}],"exchange":"NASDAQ","name":"Tscan Therapeutics, Inc.","nameEN":"Tscan Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tscan Therapeutics, Inc.(TCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tscan Therapeutics, Inc.(TCRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tscan Therapeutics, Inc.,TCRX,Tscan Therapeutics, Inc.股票,Tscan Therapeutics, Inc.股票老虎,Tscan Therapeutics, Inc.股票老虎国际,Tscan Therapeutics, Inc.行情,Tscan Therapeutics, Inc.股票行情,Tscan Therapeutics, Inc.股价,Tscan Therapeutics, Inc.股市,Tscan Therapeutics, Inc.股票价格,Tscan Therapeutics, Inc.股票交易,Tscan Therapeutics, Inc.股票购买,Tscan Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tscan Therapeutics, Inc.(TCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tscan Therapeutics, Inc.(TCRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}